IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
13. September 2023 09:15 ET
|
IR-Med, Inc.
Served as Chief FDA Counsel for Revlon and Johnson & Johnson, as a Board Member at Johnson & Johnson Development Corporation, that company’s strategic venture capital division, and as patent...